Left ventricular aneurysm medical therapy: Difference between revisions
No edit summary |
No edit summary |
||
(6 intermediate revisions by one other user not shown) | |||
Line 3: | Line 3: | ||
{{CMG}};{{AE}}{{MehdiP}} | {{CMG}};{{AE}}{{MehdiP}} | ||
==Overview== | ==Overview== | ||
Afterload reduction and treatment anginal pain are the | [[Afterload]] reduction and treatment of [[Angina Pectoris|anginal pain]], are the mainstay of medical therapy for small and medium-sized LV aneurysms. | ||
==Medical Therapy== | ==Medical Therapy== | ||
Medical therapy is indicated for small and medium sized LV aneurysms. | Medical therapy is indicated for small and medium-sized LV aneurysms. The aim of medical therapy is to decrease cardiac work load (afterload reduction), provide anti ischemic therapy for [[chest pain]], and [[Anti coagulation therapy|anti coagulation]] if [[Thrombosis|mural thrombosis]] exist.<ref name="brawn">{{cite book | last = Mann | first = Douglas | title = Braunwald's heart disease : a textbook of cardiovascular medicine | publisher = Elsevier/Saunders | location = Philadelphia, PA | year = 2015 | isbn = 978-1455751341 }}</ref> | ||
*Afterload reduction: | *[[Afterload]] reduction: | ||
:ACE inhibitors are the drug of choice for decreasing the afterload. | :[[ACE inhibitor|ACE inhibitors]] are the drug of choice for decreasing the [[afterload]]. | ||
*Anti ischemic therapy: | *Anti ischemic therapy: | ||
:Many medications can be used to treat underlying ischemic event | :Many medications can be used to treat the underlying ischemic event, and also decrease the ischemic burden. Examples of such medications include:<ref name="brawn">{{cite book | last = Mann | first = Douglas | title = Braunwald's heart disease : a textbook of cardiovascular medicine | publisher = Elsevier/Saunders | location = Philadelphia, PA | year = 2015 | isbn = 978-1455751341 }}</ref> | ||
'''[[Chronic stable angina nitrate therapy|Nitrates]] | [[Chronic stable angina beta blocker therapy|Beta Blockers]] | [[Chronic stable angina treatment calcium channel blockers|Calcium Channel Blockers]] | [[Chronic stable angina treatment potassium channel openers|Potassium Channel Openers]] | [[Chronic stable angina newer antianginal agents|Newer Anti-anginal Agents]]''' | :'''[[Chronic stable angina nitrate therapy|Nitrates]] | [[Chronic stable angina beta blocker therapy|Beta Blockers]] | [[Chronic stable angina treatment calcium channel blockers|Calcium Channel Blockers]] | [[Chronic stable angina treatment potassium channel openers|Potassium Channel Openers]] | [[Chronic stable angina newer antianginal agents|Newer Anti-anginal Agents]]''' | ||
Latest revision as of 05:29, 9 April 2017
Left ventricular aneurysm Microchapters |
Differentiating Left ventricular aneurysm from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Left ventricular aneurysm medical therapy On the Web |
American Roentgen Ray Society Images of Left ventricular aneurysm medical therapy |
Risk calculators and risk factors for Left ventricular aneurysm medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Seyedmahdi Pahlavani, M.D. [2]
Overview
Afterload reduction and treatment of anginal pain, are the mainstay of medical therapy for small and medium-sized LV aneurysms.
Medical Therapy
Medical therapy is indicated for small and medium-sized LV aneurysms. The aim of medical therapy is to decrease cardiac work load (afterload reduction), provide anti ischemic therapy for chest pain, and anti coagulation if mural thrombosis exist.[1]
- Afterload reduction:
- ACE inhibitors are the drug of choice for decreasing the afterload.
- Anti ischemic therapy:
- Many medications can be used to treat the underlying ischemic event, and also decrease the ischemic burden. Examples of such medications include:[1]
- Nitrates | Beta Blockers | Calcium Channel Blockers | Potassium Channel Openers | Newer Anti-anginal Agents
References
- ↑ 1.0 1.1 Mann, Douglas (2015). Braunwald's heart disease : a textbook of cardiovascular medicine. Philadelphia, PA: Elsevier/Saunders. ISBN 978-1455751341.